Radio Interview: Dr. Amy Shapiro discusses HEMLIBRA
Indiana Hemophilia & Thrombosis Center's Dr. Amy Shapiro discussed the new novel therapy, HEMLIBRA, with the hosts of Caregiver Crossing,...
FOX59 Video: FDA approves new bleeding disorder drug
Changing the life of an Indiana two-year-old with the approved use of a new drug. Two-year-old Griffin Picket was enduring...
HEMLIBRA® now option for those with, without inhibitor (Hemophilia A)
On October 4, 2018, the FDA approved HEMLIBRA ® for prevention (prophylaxis) of bleeding episodes in adults and children ages...
New agent joins hydroxyurea as FDA-approved sickle cell treatment
By Dana LeBlanc, M.D., and Emily Riehm Meier, M.D., M.S.H.S., FAAP
Sickle cell disease (SCD) affects 70,000-100,000 Americans and...
Amish Mutation Protects Against Diabetes and May Extend Life
By Anahad O'Connor
Amish people living in a rural part of Indiana have a rare genetic mutation that protects...
8326 Naab Road
Indianapolis, IN 46260
View on Twitter